tiprankstipranks
Advertisement
Advertisement
Arbutus Biopharma Reshapes Strategy After Moderna Settlement
PremiumCompany AnnouncementsArbutus Biopharma Reshapes Strategy After Moderna Settlement
1M ago
Arbutus Biopharma expects to return $230M in capital to shareholders
Premium
The Fly
Arbutus Biopharma expects to return $230M in capital to shareholders
1M ago
Arbutus initiates patent infringement actions against Pfizer, BioNTech
Premium
The Fly
Arbutus initiates patent infringement actions against Pfizer, BioNTech
1M ago
Arbutus Biopharma Gains FDA Fast Track for Imdusiran
PremiumCompany AnnouncementsArbutus Biopharma Gains FDA Fast Track for Imdusiran
4M ago
Arbutus Biopharma granted Fast Track designation for imdusiran
Premium
The Fly
Arbutus Biopharma granted Fast Track designation for imdusiran
4M ago
Roivant Sciences price target raised to $34 from $30 at Jefferies
Premium
The Fly
Roivant Sciences price target raised to $34 from $30 at Jefferies
5M ago
Morning News Wrap-Up 3/4/26: Wednesday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up 3/4/26: Wednesday’s Biggest Stock Market Stories!
6M ago
Unusually active option classes on open March 4th
Premium
The Fly
Unusually active option classes on open March 4th
6M ago
Video: Moderna advances as settlement seen removing share overhang
Premium
The Fly
Video: Moderna advances as settlement seen removing share overhang
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100